{"id":6170,"date":"2022-06-15T10:47:46","date_gmt":"2022-06-15T08:47:46","guid":{"rendered":"https:\/\/www.rapharm.eu\/hr\/?p=6170"},"modified":"2022-06-15T10:51:14","modified_gmt":"2022-06-15T08:51:14","slug":"eu-obustavljena-procjena-kanabidiola-cbd-kao-nove-hrane","status":"publish","type":"post","link":"https:\/\/www.rapharm.eu\/hr\/eu-obustavljena-procjena-kanabidiola-cbd-kao-nove-hrane\/","title":{"rendered":"EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane"},"content":{"rendered":"<style type=\"text\/css\"><\/style>\n<p>Europska agencija za sigurnost hrane (EFSA)\nobustavlja ocjenjivanje CBD-a kao nove hrane, budu\u0107i da trenuta\u010dna znanstvena\ndokumentacija ne utvr\u0111uje sigurnost &nbsp;CBD-a u hrani, uglavnom zbog nedostatka\ndokumentacije, odre\u0111enih nejasno\u0107a i potencijalnih rizika povezanih s\nkori\u0161tenjem CBD-a.<\/p>\n\n\n\n<p>Predstavnik EFSA-e prof. Dominique Turck je\nkazao kako su tijekom evaluacije utvr\u0111eni odre\u0111eni rizici u vezi s kori\u0161tenjem\nCBD-a, koji se moraju otkloniti dopunom znanstvene dokumentacije prije nastavka\nrada. Pritom tako\u0111er isti\u010de da to ne zna\u010di da su zaklju\u010dili da je CBD opasan\nkao hrana.<\/p>\n\n\n\n<p>Nedostatak dokumentacije odnosi se uglavnom\nna u\u010dinke CBD-a na jetru, probavni trakt, endokrini i \u017eiv\u010dani sustav te\npsihi\u010dko blagostanje ljudi.<\/p>\n\n\n\n<p><strong>Trebate li dodatno znanje ili pomo\u0107 u\nprovjeri sukladnosti sastojaka i drugih svojstava proizvoda prije ulaska na\ntr\u017ei\u0161te?<\/strong><\/p>\n\n\n\n<p>Uz pomo\u0107 na\u0161ih <a href=\"https:\/\/www.rapharm.eu\/hr\/savjetovanje-i-usluge\/\">savjetovanja<\/a> u potpunosti Vam mo\u017eemo pomo\u0107i u temeljitim\npregledima sukladnosti proizvoda za ulazak na va\u0161e tr\u017ei\u0161te, kao i na inozemna\ntr\u017ei\u0161ta te mogu\u0107nosti legalnog marketinga dodataka prehrani.<\/p>\n\n\n\n<p>Vir: <\/p>\n\n\n\n<p><a href=\"https:\/\/www.efsa.europa.eu\/en\/news\/cannabidiol-novel-food-evaluations-hold-pending-new-data\">Cannabidiol\nnovel food evaluations on hold pending new data | EFSA (europa.eu)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Europska agencija za sigurnost hrane (EFSA) obustavlja ocjenjivanje CBD-a kao nove hrane, budu\u0107i da trenuta\u010dna znanstvena dokumentacija ne utvr\u0111uje sigurnost &nbsp;CBD-a u hrani, uglavnom zbog nedostatka dokumentacije, odre\u0111enih nejasno\u0107a i potencijalnih rizika povezanih s kori\u0161tenjem CBD-a. Predstavnik EFSA-e prof. Dominique Turck je kazao kako su tijekom evaluacije utvr\u0111eni odre\u0111eni rizici u vezi s kori\u0161tenjem CBD-a,&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46,31],"tags":[],"class_list":["post-6170","post","type-post","status-publish","format-standard","hentry","category-novice-hr","category-uncategorized-hr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane - raPHARM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane - raPHARM\" \/>\n<meta property=\"og:description\" content=\"Europska agencija za sigurnost hrane (EFSA) obustavlja ocjenjivanje CBD-a kao nove hrane, budu\u0107i da trenuta\u010dna znanstvena dokumentacija ne utvr\u0111uje sigurnost &nbsp;CBD-a u hrani, uglavnom zbog nedostatka dokumentacije, odre\u0111enih nejasno\u0107a i potencijalnih rizika povezanih s kori\u0161tenjem CBD-a. Predstavnik EFSA-e prof. Dominique Turck je kazao kako su tijekom evaluacije utvr\u0111eni odre\u0111eni rizici u vezi s kori\u0161tenjem CBD-a,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/\" \/>\n<meta property=\"og:site_name\" content=\"raPHARM\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-15T08:47:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-15T08:51:14+00:00\" \/>\n<meta name=\"author\" content=\"rapharm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rapharm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/\",\"url\":\"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/\",\"name\":\"EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane - raPHARM\",\"isPartOf\":{\"@id\":\"https:\/\/www.rapharm.eu\/#website\"},\"datePublished\":\"2022-06-15T08:47:46+00:00\",\"dateModified\":\"2022-06-15T08:51:14+00:00\",\"author\":{\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rapharm.eu\/hr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rapharm.eu\/#website\",\"url\":\"https:\/\/www.rapharm.eu\/\",\"name\":\"raPHARM\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rapharm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\",\"name\":\"rapharm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"caption\":\"rapharm\"},\"url\":\"https:\/\/www.rapharm.eu\/hr\/author\/rapharm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane - raPHARM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/","og_locale":"hr_HR","og_type":"article","og_title":"EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane - raPHARM","og_description":"Europska agencija za sigurnost hrane (EFSA) obustavlja ocjenjivanje CBD-a kao nove hrane, budu\u0107i da trenuta\u010dna znanstvena dokumentacija ne utvr\u0111uje sigurnost &nbsp;CBD-a u hrani, uglavnom zbog nedostatka dokumentacije, odre\u0111enih nejasno\u0107a i potencijalnih rizika povezanih s kori\u0161tenjem CBD-a. Predstavnik EFSA-e prof. Dominique Turck je kazao kako su tijekom evaluacije utvr\u0111eni odre\u0111eni rizici u vezi s kori\u0161tenjem CBD-a,...","og_url":"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/","og_site_name":"raPHARM","article_published_time":"2022-06-15T08:47:46+00:00","article_modified_time":"2022-06-15T08:51:14+00:00","author":"rapharm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rapharm","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/","url":"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/","name":"EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane - raPHARM","isPartOf":{"@id":"https:\/\/www.rapharm.eu\/#website"},"datePublished":"2022-06-15T08:47:46+00:00","dateModified":"2022-06-15T08:51:14+00:00","author":{"@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1"},"breadcrumb":{"@id":"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rapharm.eu\/evalvacija-kanabidiola-cbd-kot-novo-zivilo-zacasno-ustavljena\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rapharm.eu\/hr\/"},{"@type":"ListItem","position":2,"name":"EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane"}]},{"@type":"WebSite","@id":"https:\/\/www.rapharm.eu\/#website","url":"https:\/\/www.rapharm.eu\/","name":"raPHARM","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rapharm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Person","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1","name":"rapharm","image":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","caption":"rapharm"},"url":"https:\/\/www.rapharm.eu\/hr\/author\/rapharm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/6170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/comments?post=6170"}],"version-history":[{"count":1,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/6170\/revisions"}],"predecessor-version":[{"id":6171,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/6170\/revisions\/6171"}],"wp:attachment":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/media?parent=6170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/categories?post=6170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/tags?post=6170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}